Characteristics of Laryngeal Osteosarcoma: A Critical Review.

Larynx Osteosarcoma Radiotherapy Sarcoma Surgery

Journal

Oncology and therapy
ISSN: 2366-1089
Titre abrégé: Oncol Ther
Pays: New Zealand
ID NLM: 101677510

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 13 01 2020
entrez: 24 7 2020
pubmed: 24 7 2020
medline: 24 7 2020
Statut: ppublish

Résumé

Laryngeal sarcomas constitute an extremely rare entity among head and neck malignancies. Furthermore, most of them are chondrosarcomas, and the osteogenic form remains a true rarity. In general, there is a lack of information on the characteristics of laryngeal osteosarcoma. Thus, we sought to critically review the existing world literature on laryngeal osteosarcoma in order to develop a more accurate clinicopathological profile of this malignancy. Laryngeal osteosarcoma has a predilection for elderly male patients, as 87% were male in the present series and the mean age was 62 years (range 32-80), and without a direct association with tobacco exposure. Osteosarcoma of the larynx is typically a highly malignant neoplasm that metastasizes early, has a propensity for hematogenous spread and also has a marked tendency to recur. Twelve (41%) out of the 29 cases in the present review with follow-up data had metastatic disease. The aspects that distinguish osteosarcoma from its differential diagnostic alternatives are discussed in this review.

Identifiants

pubmed: 32700074
doi: 10.1007/s40487-020-00110-8
pii: 10.1007/s40487-020-00110-8
pmc: PMC7359981
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

33-44

Références

Arch Otolaryngol. 1946 Nov;44(5):517-24
pubmed: 20275854
BMJ Case Rep. 2014 Oct 16;2014:
pubmed: 25323286
Otolaryngol Pol. 2005;59(2):285-8
pubmed: 16095104
Laryngoscope. 1966 Feb;76(2):325-33
pubmed: 5217119
J Med Assoc Thai. 1981 Jun;64(6):301-7
pubmed: 6943268
Contemp Oncol (Pozn). 2015;19(3):246-9
pubmed: 26557767
Ann Otol Rhinol Laryngol. 1994 Feb;103(2):160-3
pubmed: 8311393
Arch Otolaryngol Head Neck Surg. 1998 Feb;124(2):207-10
pubmed: 9485115
Otolaryngol Head Neck Surg. 2004 Nov;131(5):789-90
pubmed: 15523469
J BUON. 2008 Jul-Sep;13(3):437-9
pubmed: 18979564
Ann Diagn Pathol. 2018 Dec;37:35-41
pubmed: 30241033
J Laryngol Otol. 1973 Oct;87(10):997-1005
pubmed: 4517970
HNO. 1983 Oct;31(10):366-8
pubmed: 6580287
Cancer. 1978 Nov;42(5):2343-51
pubmed: 281260
Arch Otolaryngol. 1978 Aug;104(8):477-81
pubmed: 277137
Head Neck. 1997 Jan;19(1):57-62
pubmed: 9030947
Head Neck. 2015 Feb;37(2):E26-9
pubmed: 24824784
J Otolaryngol. 2002 Jun;31(3):189-92
pubmed: 12121029
Cancer. 1988 Dec 1;62(11):2330-40
pubmed: 3179948
J Cancer Res Ther. 2015 Oct-Dec;11(4):1038
pubmed: 26881648
Laryngoscope. 2005 Jan;115(1):74-7
pubmed: 15630370
Ann Diagn Pathol. 2002 Feb;6(1):1-9
pubmed: 11842374
Cases J. 2008 Dec 01;1(1):365
pubmed: 19046454
Head Neck Pathol. 2015 Mar;9(1):158-64
pubmed: 24947052
Otolaryngol Head Neck Surg. 1998 Mar;118(3 Pt 1):385-8
pubmed: 9527123
Ann Otol Rhinol Laryngol. 1998 Jan;107(1):70-4
pubmed: 9439392
Ann Otol Rhinol Laryngol. 1989 Dec;98(12 Pt 1):971-4
pubmed: 2589767
Otolaryngol Head Neck Surg. 1990 Mar;102(3):276-80
pubmed: 2108418
Arch Otolaryngol. 1980 Jan;106(1):8-12
pubmed: 6928099
Rare Tumors. 2017 Mar 24;9(1):6955
pubmed: 28458793
Head Neck Pathol. 2019 Dec 7;:
pubmed: 31813100
Harefuah. 1996 Jun 2;130(11):740-4, 799
pubmed: 8794675
Arch Iran Med. 2009 Sep;12(5):499-502
pubmed: 19722775
Ear Nose Throat J. 2012 Oct;91(10):E22-5
pubmed: 23076859

Auteurs

Antti A Mäkitie (AA)

Department of Otorhinolaryngology, Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. antti.makitie@helsinki.fi.
Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland. antti.makitie@helsinki.fi.
Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet and Karolinska Hospital, Stockholm, Sweden. antti.makitie@helsinki.fi.
Sorbonne université, Service d'oto-rhino-laryngologie et de chirurgie cervicofaciale, DMU CHIR, Hôpital Tenon, Assistance-Publique-Hôpitaux de Paris, 4, rue de la Chine, 75020, Paris, France. antti.makitie@helsinki.fi.

Kenneth O Devaney (KO)

Department of Pathology, Allegiance Health, Jackson, MI, USA.

Bertrand Baujat (B)

Sorbonne université, Service d'oto-rhino-laryngologie et de chirurgie cervicofaciale, DMU CHIR, Hôpital Tenon, Assistance-Publique-Hôpitaux de Paris, 4, rue de la Chine, 75020, Paris, France.
EURACAN (European Rare Cancer Network) Group 7 Head and Neck rare tumours, Paris, France.
REFCOR (Réseau d'Expertise Français sur les cancers ORL Rares), Paris, France.

Alhadi Almangush (A)

Department of Pathology, University of Helsinki, Helsinki, Finland.
Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.
Institute of Dentistry, University of Misurata, Misurata, Libya.

Alfio Ferlito (A)

Coordinator of the International Head and Neck Scientific Group, Padua, Italy.

Classifications MeSH